Finger/Hand/Wrist Replacement

The company marked the 100th implantation of Ensemble CMC for the treatment of carpometacarpal osteoarthritis.

Designed to preserve natural motion and maximize stability, the system offers an alternative to wrist fusion.

The modular system replaces the radial and carpal sides of the wrist to treat rheumatoid arthritis, osteoarthritis or post-traumatic arthritis.

Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development....

KinematX is the only midcarpal implant designed to mimic the natural range of motion in patients with wrist arthritis and other conditions.

Ensemble CMC™, the first implant in a product line of minimally invasive joint replacements for the hand and wrist.

The Ensemble CMC was designed to treat early-stage osteoarthritis of the carpometacarpal joint using a minimally invasive procedure.

With this partnership, Medartis takes a significant step towards becoming a complete solution provider in its strongest segment: hand and wrist.

STAR is one of the first total ankle systems in the market and the Silicone, Surface Replacement and TACTYS finger portfolio holds a leading global market position.

WristMotion is indicated for replacement of the painful wrist joint due to rheumatoid arthritis, osteoarthritis or post-traumatic arthritis.

To clear regulatory issues related to its purchase of Wright Medical, Stryker proposed DJO as a buyer for certain ankle and finger joint replacement lines.

Integra Lifesciences announced a definitive agreement to divest its Extremity Orthopedics business to Smith+Nephew for $240 million.

Extremity Medical received FDA 510(k) clearance for the KinematX Total Wrist. Launch will occur by the end of 2020.

Ortho Consulting Group Holdings acquired Osteotec, a U.K.-based orthopedic device distributor and manufacturer.